Long-term follow-up confirms a survival advantage of the paclitaxel–cisplatin regimen over the cyclophosphamide–cisplatin combination in advanced ovarian cancer
M. J. Piccart, K. Bertelsen, G. Stuart, J. Cassidy, C. Mangioni, E. Simonsen, K. James, S. Kaye, I. Vergote, R. Blom, R. Grimshaw, R. Atkinson, K. Swenerton, C. Trope, M. Nardi, J. Kaern, S. Tumolo, PVolume:
13
Year:
2003
Language:
english
Pages:
5
DOI:
10.1111/j.1525-1438.2003.13357.x
File:
PDF, 102 KB
english, 2003